|
1
|
|
$62.7M
|
+$24.3M
|
+11,055,868
|
+58%
|
|
|
2
|
|
$46.9M
|
–
|
–
|
–
|
|
|
3
|
Frazier Life Sciences Management
Palo Alto,
California
|
$46.7M
|
+$41M
|
+18,650,000
|
+491%
|
|
|
4
|
State Street
Boston,
Massachusetts
|
$39.6M
|
+$22.8M
|
+10,365,520
|
+120%
|
|
|
5
|
TPG GP A
Fort Worth,
Texas
|
$38.9M
|
–
|
–
|
–
|
|
|
6
|
Sio Capital Management
New York
|
$27.7M
|
+$29.3M
|
+13,323,431
|
New
|
|
|
7
|
Primecap Management
Pasadena,
California
|
$27.3M
|
+$10.4M
|
+4,743,600
|
+57%
|
|
|
8
|
Vanguard Capital Management
Malvern,
Pennsylvania
|
$25.3M
|
+$11.5M
|
+5,245,286
|
+76%
|
|
|
9
|
Fidelity Investments
Boston,
Massachusetts
|
$25M
|
+$22.9M
|
+10,419,213
|
+655%
|
|
|
10
|
Citadel Advisors
Miami,
Florida
|
$21M
|
+$7.23M
|
+3,294,150
|
+48%
|
|
|
11
|
Two Sigma Investments
New York
|
$16.2M
|
+$5.29M
|
+2,408,892
|
+45%
|
|
|
12
|
Geode Capital Management
Boston,
Massachusetts
|
$14.7M
|
+$6.42M
|
+2,925,150
|
+71%
|
|
|
13
|
|
$12.8M
|
+$7.43M
|
+3,382,715
|
+122%
|
|
|
14
|
GordonMD Global Investments
Beverely Hills,
California
|
$11M
|
+$8.49M
|
+3,868,000
|
+270%
|
|
|
15
|
Marshall Wace
London,
United Kingdom
|
$10.6M
|
+$3.62M
|
+1,647,424
|
+48%
|
|
|
16
|
Patient Square Capital
Menlo Park,
California
|
$10.5M
|
+$3.51M
|
+1,600,000
|
+46%
|
|
|
17
|
Aberdeen Group
Edinburgh,
United Kingdom
|
$10.4M
|
+$7.77M
|
+3,539,533
|
+242%
|
|
|
18
|
Millennium Management
New York
|
$10.1M
|
+$3.34M
|
+1,521,836
|
+46%
|
|
|
19
|
|
$9.8M
|
+$4.28M
|
+1,946,959
|
+70%
|
|
|
20
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$9.65M
|
-$1.63M
|
-741,619
|
-14%
|
|
|
21
|
|
$9.38M
|
+$7.71M
|
+3,511,117
|
+352%
|
|
|
22
|
Woodline Partners
San Francisco,
California
|
$9.36M
|
+$2.2M
|
+999,546
|
+29%
|
|
|
23
|
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$9.01M
|
+$2.94M
|
+1,338,978
|
+45%
|
|
|
24
|
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
$8.76M
|
+$5.53M
|
+2,517,966
|
+149%
|
|
|
25
|
Renaissance Technologies
New York
|
$7.98M
|
+$3.72M
|
+1,694,984
|
+79%
|
|
